Howard Rosen has joined Intact Vascular’s executive management team as vice president of marketing and business development. In this position, Rosen will lead the company’s efforts to prepare for commercialisation of its Tack Endovascular System for the repair of dissections following peripheral artery angioplasty.
“Howard brings deep experience in both upstream and downstream marketing, as well as first-hand knowledge of the peripheral vascular marketplace and our customers,” said Bruce J Shook, Intact Vascular’s president and chief executive officer. “Howard is a welcome addition to our team as we move through the pre-market approval (PMA) application process and toward market introduction of our products,” Shook continued.
Prior to joining Intact Vascular, Rosen’s career included twenty-one years at Boston Scientific, where he began his career as a sales representative and rose through the marketing ranks to hold positions of increasing responsibility in the peripheral vascular interventions and cardiovascular businesses. Rosen most recently served as vice president of the cell processing franchise at Haemonetics.
“Intact Vascular has created a novel solution to the widespread problem of dissections following angioplasty, and the company has made a significant investment in clinical research. I am excited to build on that strong foundation and bring this important technology to clinicians and their patients,” said Rosen.